Pneumonectomy in children for destroyed lung: evaluation of 18 cases

Altug Kosar1, Alpay Orki, Hakan Kiral

  • 1Sureyyapasa Chest Disease and Chest Surgery Training and Research Hospital, Istanbul, Turkey. altugkosar@yahoo.com

Insights

Pneumonectomy is a safe surgical option for children with destroyed lung, a nonfunctional lung caused by inflammation. This procedure shows acceptable morbidity and mortality rates, allowing children to develop normally post-surgery.

Area of Science:

  • Pediatric Surgery
  • Thoracic Medicine
  • Pulmonology

Background:

  • Destroyed lung is a rare, nonfunctional lung condition often resulting from inflammatory diseases.
  • Surgical resection, specifically pneumonectomy, is a treatment option for destroyed lung in children to manage complications and enhance quality of life.

Purpose of the Study:

  • To review the surgical experience with pneumonectomy for destroyed lung in pediatric patients.
  • To evaluate the outcomes, complications, and long-term development following pneumonectomy in children.

Main Methods:

  • Retrospective analysis of 18 children (aged 16 or younger) who underwent pneumonectomy for destroyed lung between 1991 and 2007.
  • Data collected included presenting symptoms, diagnostic methods, pathologies, surgical details, complications, and follow-up information.

Main Results:

  • Eighteen children (mean age 12.3 years) underwent pneumonectomy; cough was the primary symptom.
  • Common pathologies included bronchiectasis, tuberculosis, and aspergillosis.
  • No mortality occurred; complications included atelectasis, fistula, empyema, and wound infection. Long-term follow-up showed normal growth and development in children.

Conclusions:

  • Pneumonectomy is associated with acceptable morbidity and mortality in selected pediatric patients with destroyed lung.
  • Appropriate antibiotic and antituberculosis treatment, alongside optimal surgical timing, are crucial for successful outcomes.
  • Children undergoing pneumonectomy for destroyed lung can achieve normal growth and development.
Abstract

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: